Clinical Trial Update: Pilot Study Evaluating the Safety and Performance of the GeNO NITROsyl Delivery System for Inhaled Nitric Oxide [Phase 2]

View source ↗

Summary

This Phase 2 pilot trial evaluated the safety and performance of the GeNO NITROsyl inhaled nitric oxide delivery system in patients with pulmonary arterial hype…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Snippet

Sponsor: Geno LLC | Conditions: Pulmonary Arterial Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2013-06-04